These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16870675)

  • 21. Apolipoprotein E, CI and B gene polymorphisms in a sample of patients with coronary heart disease in the Kuwaiti population.
    Al-Bustan SA; Alkhalaf M; Al-Rashdan I; Al-Otaibi S; Al-Baker E; Balding D; Alnaqeeb MA
    Med Princ Pract; 2009; 18(4):294-9. PubMed ID: 19494537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen and cardiovascular disease: genetics and biomarkers.
    Tousoulis D; Papageorgiou N; Androulakis E; Briasoulis A; Antoniades C; Stefanadis C
    Blood Rev; 2011 Nov; 25(6):239-45. PubMed ID: 21652129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden.
    Green F; Hamsten A; Blombäck M; Humphries S
    Thromb Haemost; 1993 Dec; 70(6):915-20. PubMed ID: 8165611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome.
    Mälarstig A; Wallentin L; Siegbahn A
    Thromb Res; 2007; 119(4):467-73. PubMed ID: 16782174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
    Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
    Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.
    Sabatine MS; Ploughman L; Simonsen KL; Iakoubova OA; Kirchgessner TG; Ranade K; Tsuchihashi Z; Zerba KE; Long DU; Tong CH; Packard CJ; Pfeffer MA; Devlin JJ; Shepherd J; Campos H; Sacks FM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):562-7. PubMed ID: 18174457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population.
    Marott SC; Nordestgaard BG; Zacho J; Friberg J; Jensen GB; Tybjaerg-Hansen A; Benn M
    J Am Coll Cardiol; 2010 Aug; 56(10):789-95. PubMed ID: 20797493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
    Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
    Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.
    Sie MP; Sayed-Tabatabaei FA; Oei HH; Uitterlinden AG; Pols HA; Hofman A; van Duijn CM; Witteman JC
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):212-7. PubMed ID: 16269662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
    Grünbacher G; Weger W; Marx-Neuhold E; Pilger E; Köppel H; Wascher T; März W; Renner W
    Thromb Res; 2007; 121(1):33-6. PubMed ID: 17445871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease.
    Burr D; Doss H; Cooke GE; Goldschmidt-Clermont PJ
    Stat Med; 2003 May; 22(10):1741-60. PubMed ID: 12720308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between fibrinogen Bß-148C/T polymorphism and coronary artery lesions in children with Kawasaki disease].
    Gao J; Wang HY; Wu NJ; Zhang SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):518-20. PubMed ID: 20637145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the association of -689C/T polymorphism in the PPARgamma2 promoter with myocardial infarction].
    Li JP; Cheng LX; He MA; Wu TC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):19-22. PubMed ID: 18247297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study).
    März W; Scharnagl H; Hoffmann MM; Boehm BO; Winkelmann BR
    Eur Heart J; 2004 Dec; 25(23):2109-19. PubMed ID: 15571826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil elastase gene variation and coronary heart disease.
    Schönfelder J; Telgmann R; Nicaud V; Brand E; Dördelmann C; Rüssmann C; Beining K; Schmidt-Petersen K; Evans A; Kee F; Morrison C; Arveiler D; Cambien F; Paul M; Brand-Herrmann SM
    Pharmacogenet Genomics; 2007 Aug; 17(8):629-37. PubMed ID: 17622939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study.
    Fisher E; Stefan N; Saar K; Drogan D; Schulze MB; Fritsche A; Joost HG; Häring HU; Hubner N; Boeing H; Weikert C
    Circ Cardiovasc Genet; 2009 Dec; 2(6):607-13. PubMed ID: 20031641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.